Cochrane Abstracts
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease Edited (no change to conclusions)
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Combined Corticosteroid and Long‐acting Beta2‐agonist in One Inhaler Versus Inhaled Corticosteroids Alone for Chronic Obstructive Pulmonary Disease Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431258/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_inhaled_corticosteroids_alone_for_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_. Accessed 22 May 2022.
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431258/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_inhaled_corticosteroids_alone_for_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_. Accessed May 22, 2022.
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431258/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_inhaled_corticosteroids_alone_for_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_
Combined Corticosteroid and Long‐acting Beta2‐agonist in One Inhaler Versus Inhaled Corticosteroids Alone for Chronic Obstructive Pulmonary Disease Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2022 May 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431258/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_inhaled_corticosteroids_alone_for_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease Edited (no change to conclusions)
ID - 431258
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431258/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_inhaled_corticosteroids_alone_for_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
